EMA Authorised: Pioglitazone Actavis (pioglitazone hydrochloride) — Actavis Group PTC ehf

View source ↗

Summary

Authorisation granted for Pioglitazone Actavis (pioglitazone hydrochloride) for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pioglitazone Actavis (pioglitazone hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Actavis Group PTC ehf. Decision date: 31/05/2023